Purple Biotech Ltd. (PPBT) stock
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71+0.03 (+1.79%)
Close on Nov 17, 2026Market cap $1.59MP/E 0.0Yield –
Purple Biotech operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2023 it was -$22.27M. The highest annual figure on record is -$4.07M in fiscal 2015.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$22.27M | – |
| FY2022 | Dec 31, 2022 | -$22.60M | – |
| FY2021 | Dec 31, 2021 | -$17.93M | – |
| FY2020 | Dec 31, 2020 | -$12.61M | – |
| FY2019 | Dec 31, 2019 | -$7.16M | – |
| FY2018 | Dec 31, 2018 | -$7.83M | – |
| FY2017 | Dec 31, 2017 | -$11.97M | – |
| FY2016 | Dec 31, 2016 | -$7.18M | – |
| FY2015 | Dec 31, 2015 | -$4.07M | – |
See a number that looks wrong?